Developing and testing safe vaccines for COVID-19.
CIVIC: VACCINE MANUFACTURING AND TOXICOLOGY CORE FOR SARS-CoV-2
This study is working on new types of vaccines for COVID-19 to make sure they are safe and effective, so people can have better protection against the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10788139 on NIH RePORTER |
What this research studies
This research focuses on creating and evaluating innovative vaccine platforms specifically for the SARS-CoV-2 virus, which causes COVID-19. The team will utilize advanced manufacturing techniques to formulate these vaccines and rigorously assess their safety and potential toxic effects. By optimizing these processes, the research aims to ensure that the vaccines are both effective and safe for public use. Patients may benefit from the development of new vaccines that could provide better protection against COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals who are at risk for COVID-19 or those interested in receiving innovative vaccine options.
Not a fit: Patients who are not at risk for COVID-19 or those who have already received a sufficient vaccine may not receive additional benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective vaccines for COVID-19.
How similar studies have performed: Other research has shown success in developing vaccines for viral infections, indicating that innovative approaches in this area can be effective.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Denny, Thomas — Duke University
- Study coordinator: Denny, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.